openPR Logo
Press release

Biomarkers Summit

01-10-2011 12:57 PM CET | Health & Medicine

Press release from: SMi Group

SMi present their 4th annual conference on
Biomarkers Summit
Monday 31st January & Tuesday 1st February 2011
Crowne Plaza The-City, London, UK

Don’t Miss Out - Visit to register your place today
http://www.smi-online.co.uk/preclinical-biomarkers.asp

Sponsored by
Caprotec
Cell Signalling Technology
GVK Bio
Selventa
Millipore Quest Diagnostics
RBM

SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out to secure your place before all attendee places are gone!
The Biomarker Summit will address new developments in Biomarker Discovery, Validation, and Qualification, Stratification Biomarkers in Personalised Medicine, Pharmacology Biomarkers and PK/PD modelling and informatics to Biomarker development. Presented by 29 expert speakers over two days and two distinct presentation streams covering Oncology, Immunology & CNS.

Featuring Keynote Presentations From:
• Hans Winkler, Senior Director and Global Head, Oncology Biomarkers, Johnson & Johnson
• Mark Fidock, Associate Research Fellow, Head of Quantitative Biomarkers, Pfizer
• Huseyin Mehmet, Director of Exploratory Biomarkers, Diabetes, Merck
• Ziad Taib, Statistical Science Director, Astrazeneca

Click here to view the full list of all 29 Speakers and their presentations -
http://www.smi-online.co.uk/preclinical-biomarkers.asp

Why not attend the associated workshop as well?
"Fit for Purpose Biomarkers: From Bench to Bedside"
2nd February, 2011, Crowne Plaza The-City, London, UK
Hayley Whitaker, Research Associate, University of Cambridge / Cancer Research UK
&
Ge Ruigt, Director Experimental Medicine, Merck

You should attend this event if you are involved in;
Biomarker Discovery, Validation, and Qualification
Cancer, Immunology, or CNS Biomarker R&D
Discovery Biomarkers
Translational Science
Proteomics/Genomics/Metabolomics
Clinical Pharmacology
Experimental Medicine
Biostatistics and Bioinformatics
Early Clinical Development
Preclinical Development
Drug Metabolism
Pharmacokinetics/Pharmacodynamics (PK/PD)
Personalised Medicine
Drug and Safety Assessment


To keep up to date with this event and workshop visit:
http://www.smi-online.co.uk/preclinical-biomarkers.asp

TO BOOK
SPONSORSHIP & EXHIBITION INFORMATION
SMi Group offers excellent opportunities to profile your company through tailored sponsorship and branding packages. For details contact:
Alia Malick on tel: +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk

DELEGATE BOOKINGS
Zain Philbey on: +44 (0) 20 7827 6722 or email on: zphilbey@smi-online.co.uk
Please visit www.smi-online.co.uk/preclinical-biomarkers.asp

Supported by: b3c Newswire, Bentham Science, Biocompare, Biomarkers in Medicine, BioMEV, BioNMD, Biotechniques, Business Monitor International, Canbiotech, Drug Discovery Today, European Life Sciences, Future Drugs, Going to Meet, Health Economics, Inpharm.com, Labroots, Medchem.com, Metabolomics.net, PharmaPhorum, PharmaVoice, Pharmcast, PMR, Report Buyer, SelectsScience.net, Technology Networks, Translational Biomedicine

SMi have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information.

SMi Conferences offer you an unrivalled opportunity to network within your area of business and our Workshops and Masterclasses provide an intimate, interactive forum in which to learn about the latest techniques and developments.

SMi Group Ltd,
Unit 122, Great Guildford Business Square,
30 Great Guildford Street,
London, SE1 0HS,
United Kingdom.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biomarkers Summit here

News-ID: 157797 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Bio

Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the
Global Bioplastics (Bio-plastics,Bio plastics) Market 2018 - Braskem, BASF
Apex Market Reports, recently published a detailed market research study focused on the “Bioplastics (Bio-plastics,Bio plastics) Market” across the global, regional and country level. The report provides 360° analysis of “Bioplastics (Bio-plastics,Bio plastics) Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Bioplastics
Worldwide Bio-Electronics Market 2025 – Global Analysis and Forecasts by Type …
Bio-Electronics is defined as the electronic devices used for bio-medical purposes, and helps in creating and evaluating the new technologies for better understanding of biological systems. The increasing demand of bio-electronics to meet the overwhelming need in healthcare industry will boost the bio-electronics market in forecast period. Furthermore, the growth in research of implantable devices for developing robust and reliable implantable medical devices will increase the demand of bio-electronics in
Bio Electronics and Bio Sensors Market Forecasts, 2017-2025
Description: The global bio electronic market is valued USD $15 billion in 2016 and is expected to grow at a CAGR of 11.6% during the forecast period 2017-2025. The market is driven by various factors such as rapid advancement in semiconductor technology, high demand in implantable medical devices, increasing prevalence of neural and cardiac diseases among others. The emerging healthcare technologies such as lab on chip, ambulatory surgical centres, and personalized devices are